Udai Banerji Selected Research

Udai Banerji Research Topics

Disease

68	Neoplasms (Cancer) 05/2024 - 10/2003
10	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 10/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2015
6	Melanoma (Melanoma, Malignant) 10/2017 - 04/2008
5	Breast Neoplasms (Breast Cancer) 04/2021 - 08/2007
5	Disease Progression 01/2020 - 10/2015
4	Fatigue 11/2022 - 05/2012
4	Exanthema (Rash) 11/2020 - 02/2015
3	Neutropenia 01/2023 - 12/2006
3	Carcinoma (Carcinomatosis) 01/2023 - 05/2012
3	Diarrhea 11/2022 - 02/2015
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2023 - 05/2012
2	Pneumonia (Pneumonitis) 11/2022 - 01/2020
2	Nausea 11/2022 - 01/2014
2	Pleural Effusion (Pleural Effusions) 01/2022 - 01/2016
2	Hypotension (Low Blood Pressure) 01/2020 - 01/2020
2	Hyperglycemia 01/2020 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 08/2018 - 10/2017
1	Inflammation (Inflammations) 11/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2023
1	Urticaria (Hives) 01/2023
1	Acidosis 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Anemia 11/2022
1	Cough 11/2022
1	Febrile Neutropenia 01/2022
1	Fever (Fevers) 11/2021
1	Multiple Myeloma 11/2020
1	Retinal Detachment (Retinal Detachments) 11/2020
1	Malignant Mesothelioma 01/2020
1	Mesothelioma 01/2020

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2005
10	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2007
10	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023 - 10/2003
10	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2021 - 09/2012
8	tanespimycin (17AAG)IBA 11/2018 - 11/2003
6	capivasertibIBA 04/2021 - 07/2017
5	Phosphotransferases (Kinase)IBA 04/2021 - 07/2017
5	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 12/2006
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2012
4	PhosphoproteinsIBA 01/2022 - 01/2016
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 11/2017
3	vistusertibIBA 01/2023 - 08/2015
3	CreatinineIBA 11/2020 - 05/2012
3	Estrogen ReceptorsIBA 01/2020 - 08/2014
3	Cell-Free Nucleic AcidsIBA 07/2017 - 01/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 12/2017
2	SRA737IBA 01/2023 - 01/2023
2	AntibodiesIBA 01/2023 - 01/2020
2	PlatinumIBA 01/2023 - 01/2020
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2022 - 01/2020
2	pembrolizumabIBA 01/2022 - 01/2020
2	Cetuximab (Erbitux)FDA Link 10/2021 - 01/2020
2	Fulvestrant (Faslodex)FDA Link 04/2021 - 01/2020
2	RO5126766IBA 11/2020 - 09/2012
2	AT13148IBA 01/2020 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 02/2016
2	Capsules (Microcapsules)IBA 01/2018 - 03/2010
2	Phospholipids (Phosphatides)FDA LinkGeneric 12/2017 - 11/2003
2	Adenosine Triphosphate (ATP)IBA 12/2017 - 07/2017
2	Phosphorylcholine (Phosphocholine)IBA 12/2017 - 11/2003
2	Anaplastic Lymphoma KinaseIBA 01/2017 - 01/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016 - 01/2016
2	Pemetrexed (MTA)FDA Link 01/2016 - 01/2015
2	AZD 6244IBA 02/2015 - 03/2010
2	ErbB Receptors (EGF Receptor)IBA 01/2015 - 06/2013
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 08/2014 - 07/2013
2	Histone Deacetylase InhibitorsIBA 08/2013 - 05/2012
2	Histones (Histone)IBA 08/2013 - 05/2012
1	ceralasertibIBA 11/2023
1	Gemcitabine FDA Link 01/2023
1	TroponinIBA 01/2023
1	AntigensIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	ProteomeIBA 01/2023
1	AZD3965IBA 01/2023
1	Cyclooxygenase 1IBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	Cytostatic AgentsIBA 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2022
1	Thymidylate SynthaseIBA 11/2022
1	guadecitabineIBA 01/2022
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 04/2021
1	olaparibIBA 10/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020

Therapy/Procedure

20	Therapeutics 07/2023 - 03/2010
9	Drug Therapy (Chemotherapy) 01/2020 - 12/2006
2	Precision Medicine 01/2017 - 09/2009
1	Radiotherapy 01/2024
1	Immunomodulation 01/2022